Progyny (PGNY) Cost of Revenue (2018 - 2026)

Progyny (PGNY) has 9 years of Cost of Revenue data on file, last reported at $245.4 million in Q1 2026.

• Quarterly Cost of Revenue fell 1.13% year-over-year to $245.4 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $535.3 million (down 27.23% YoY) and the FY2025 annual result came in at $984.2 million, up 1439.03% from the prior year.
• Cost of Revenue advanced to $245.4 million in Q1 2026 per PGNY's latest filing, from $18.0 million in the prior quarter.
• Across five years, Cost of Revenue topped out at $253.9 million in Q2 2025 and bottomed at $13.0 million in Q4 2022.
• The 5-year median for Cost of Revenue is $151.1 million (2022), against an average of $130.1 million.
• The widest annual swing landed in 2022, when Cost of Revenue jumped 3488.74%; it then sank 92.46% in 2024.
• Tracing PGNY's Cost of Revenue over 5 years: stood at $13.0 million in 2022, then rose by 14.88% to $14.9 million in 2023, then soared by 1476.01% to $235.0 million in 2024, then plunged by 92.35% to $18.0 million in 2025, then jumped by 1264.5% to $245.4 million in 2026.
• Per Business Quant, the three latest PGNY Cost of Revenue figures stand at $245.4 million (Q1 2026), $18.0 million (Q4 2025), and $17.9 million (Q3 2025).

Peer Comparison